Macular pigment density in age-related maculopathy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 243, Issue 3, 2005, Pages 222-227

  Jahn, Cornelia ^a   Wüstemeyer, Henrike ^b   Brinkmann, Christian ^a   Trautmann, Sandra ^a   Mößner, Andreas ^a   Wolf, Sebastian ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VISUAL PIGMENT;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; CELL DENSITY; CONFOCAL LASER MICROSCOPY; DISEASE COURSE; DRUSEN; FEMALE; HUMAN; MACULAR PIGMENT DENSITY; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; OPTOMETRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; ATROPHY; DISEASE PROGRESSION; FEMALE; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; OPHTHALMOSCOPY; RETINAL DRUSEN; RETINAL PIGMENTS; VISUAL ACUITY;

EID: 17144406907     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-004-0995-7     Document Type: Article

References (45)

1. Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose: Supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 119:1417
2. Beatty S, Boulton M, Henson D, Koh HH, Murray IJ (1999) Macular pigment and age related macular degeneration. Br J Ophthalmol 83:867-877 1:STN:280:DC%2BD3c%2Fgt1Srsw%3D%3D
3. Beatty S, Koh H-H, Henson DB, Boulton ME (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115-134 10.1016/S0039-6257(00)00140-5
4. Beatty S, Murray IJ, Henson DB, Carden D, Koh H-H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a northern European population. Invest Ophthalmol Vis Sci 42:439-446 1:STN:280:DC%2BD3M7ktFKmug%3D%3D
5. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D (2000) Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 41:3322-3326 1:STN:280:DC%2BD3cvot1yitA%3D%3D
6. Berendschot TT, Willemse-Assink JJM, Bastiaanse M, de Joung PTVM, van Norren D (2002) Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43:1928-1932 12037001
7. Bernstein PS, Yoshida MD, Katz NB, McClane RW, Gellermann W (1998) Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci 39:2003-2011 1:STN:280:DyaK1cvjt1ChsA%3D%3D
8. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PTVM, Klaver CCW, Klein BEK, Klein R, Mitchell P, Sarks JP, Sarks SH, Soubrane G, Taylor HR, Vingerling JR (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 39:367-374 1:STN:280:ByqA38fgsVQ%3D
9. Bone RA, Landrum JT, Fernandez L, Tarsis SL (1988) Analysis of the macular pigment by HPLC: Retinal distribut age study. Invest Ophthalmol Vis Sci 29:843-849 1:CAS:528:DyaL1cXkslSqtbk%3D
10. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE (2001) Macular pigment in donor eyes with and without AMD: A case-control study. Invest Ophthalmol Vis Sci 42:235-240 1:STN:280:DC%2BD3M%2Fosl2itg%3D%3D
11. Bressler NM, Bressler SB, Fine SL (1988) Age-related macular degeneration. Surv Ophthalmol 32:375-413 10.1016/0039-6257(88)90052-5
12. Cai J, Nelson DE, Wu M, Sternberg P, Jones DP (2000) Oxidative damage and protection of the RPE. Prog Retin Eye Res 19:205-221 10.1016/ S1350-9462(99)00009-9
13. Chaine G, Hullo A, Sahel J, Soubrane G, Espinasse-Berrod MA, Schutz D, Bourguignon C, Harpey C, Bourgeois H, Study-Group F-D (1998) Case-control study of the risk factors for age related macular degeneration. Br J Ophthalmol 82:996-1002 1:STN:280:DyaK1M7gvFCltw%3D%3D
14. De La Paz MA, Anderson RE (1992) Lipid peroxidation in rod outer segments. Role of hydroxyl and lipid hydroperoxides. Invest Ophthalmol Vis Sci 33:2091-2096 1607222
15. Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz L, POLA Study Group (1999) Age-related macular degeneration and antioxidant status in the POLA study. Arch Ophthalmol 117:1384-1390 1:STN:280:DC%2BD3c%2FgtVanug%3D%3D
16. Delori FC (1993) Macular pigment density measured by reflectometry and fluorometry. In: Noninvasive assessment of the Visual System. OSA Technical Digest 1993, pp. 240-243
17. Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA (2001) Macular pigment density measured by autofluorescence spectrometry: Comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am 18:1212-1130 1:STN:280:DC%2BD3MzhvV2ltg%3D%3D
18. Evans JR (2001) Risk factors for age-related macular degeneration. Prog Retin Eye Res 20:227-253 10.1016/S1350-9462(00)00023-9
19. Ham WTJ, Mueller HA, Sliney DH (1976) Retinal sensitivity to damage from short wavelength light. Nature 260:153-155 815821
20. Hammond BR Jr, Caruso-Avery M (2000) Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci 41:1492-1497 10798668
21. Hammond BRJ, Fuld K (1992) Interocular differences in macular pigment density. Invest Ophthalmol Vis Sci 33:350-355 1740365
22. Hammond BRJ, Johnson EJ, Russell RM, Krinsky NI, Yeum K-J, Edwards B, Snodderly DM (1997) Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 38:1795-1801 9286268
23. Khachik F, Bernstein PS, Garland DL (1997) Identification of lutein and zeaxanthin oxidation products in and monkey retinas. Invest Ophthalmol Vis Sci 38:1802-1811 1:STN:280:ByiH3s3jslQ%3D
24. Klein R, Klein BEK, Jensen SC (1997) The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy. The beaver dam eye study. Ophthalmology 104:1804-1812 1:STN:280:DyaK1c%2FjvV2ntQ%3D%3D
25. Landrum JT, Bone RA (2001) Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 385:28-40 10.1006/abbi.2000.2171
26. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE (1997) A one year study of the macular pigment: The effect of 140 d lutein supplement. Exp Eye Res 65:57-62 10.1006/exer.1997.0309
27. Landrum JT, Bone RA, Kilburn MD (1997) The macular pigment: A possible role in protection from age macular degeneration. Adv Pharmacol 38:537-556 1:CAS:528:DyaK2sXivVaktQ%3D%3D
28. van Leeuwen R, Chakravarthy U, Vingerling JR, Brussee C, Hooghart AJ, Mulder PG, de Jong P (2003) Grading of age-related maculopathy for epidemiological studies: Is digital imaging as good as 35-mm film? Ophthalmology 110:1540-1544 10.1016/S0161-6420(03)00501-3
29. van Leeuwen R, Klaver CCW, Vingerling JR, Hofman A, de Jong P (2003) The risk and natural course of age-related maculopathy. Arch Ophthalmol 121:519-526 10.1001/archopht.121.4.519
30. Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg GM, Klein BE, Palta M (1995) Dietary fat and age-related maculopathy. Arch Ophthalmol 113:743-748 1:STN:280:ByqA3crnslA%3D
31. McCarty CA, Mukesh BN, Fu CL (2001) Risk factors for age-related maculopathy. Arch Ophthalmol 119:1455-1462 1:STN:280:DC%2BD3MrmsVSnsw%3D%3D
32. Pauleikhoff D, Barondes MJ, Minassian D, Chisholm IH, Bird AC (1990) Drusen as risk factors in age related macular disease. Am J Ophthalmol 109:38-43 1:STN:280:By%2BC3MbmvFw%3D
33. Pauleikhoff D, Harper A, Marshall J, Bird AC (1990) Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology 97:171-178 1:STN:280:By%2BB387ksFU%3D
34. Pauleikhoff D, van Kuijk FJ, Bird AC (2001) Makuläres Pigment und altersabhängige Makuladegeneration. Ophthalmologe 98:511-519 10.1007/s003470170110
35. Robson AG, Moreland JD, Pauleikhoff D, Morrissey T, Holder GH, Fitzke FW, Bird AC, van Kuijk FJ (2003) Macular pigment density and distribution: Comparison of fundus autofluorescence with minimum motion photometry. Vision Res 43:1765-1775 10.1016/S0042-6989(03)00280-3
36. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT et al (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. J Am Med Assoc 272:1413-1420 10.1001/ jama.272.18.1413
37. Snodderly DM (1995) Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 62(Suppl 6):1448S-1461S 1:CAS:528:DyaK28XmvFWqtg%3D%3D
38. Snodderly DM, Auran JD, Delori FC (1984) The macular pigment. II Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25:674-685 1:CAS:528:DyaL2cXks12qsr8%3D
39. Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. I. Absorbance spectra, localization and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25:660-673 1:CAS:528:DyaL2cXks12qsr4%3D
40. Snodderly DM, Handelman GJ, Adler AJ (1991) Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci 32:268-279 1:STN:280:By6C3s7ivVw%3D
41. The Eye Disease Case Control Study Group (1992) Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110:1701-1708
42. Wooten BR, Hammond BRJ, Land RI, Snodderly DM (1999) A practical method for measuring macular pigment optical. Invest Ophthalmol Vis Sci 40:2481-2489 1:STN:280:DyaK1Mvjsleguw%3D%3D
43. Wüstemeyer H, Jahn C, Nestler A, Barth T, Wolf S (2002) A new instrument for the quantification of macular pigment density: First results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol 240:666-671 12192461
44. Wüstemeyer H, Moessner A, Jahn C, Wolf S (2003) Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope. Graefes Arch Clin Exp Ophthalmol 241:647-651 10.1007/s00417-003-0730-9
45. Young RW (1987) Pathophysiology of age-related macular degeneration. Surv Ophthalmol 31:291-306 10.1016/0039-6257(87)90115-9